Delivery Order SPE2DB24D2205-SPE2DB25FEHMB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,181.16 to AmerisourceBergen Drug Corp for Ofev 150 mg capsules (60-count units) on August 14, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026. The place of performance...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 150 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside award, indicating it was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ofev 150 mg capsules (60-count units) valued at $8,590.58 under a firm fixed price arrangement. The contract was competitively awarded without a set-aside designation and is scheduled for completion by August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $17,260.58. This firm fixed-price delivery order, which is expected to be completed by September 2, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ofev (nintedanib) is a medication...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ofev (nintedanib) 100 mg capsules in a 60-count unit, with a contract ceiling value of $17,260.58. This firm fixed price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by September 24, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ofev (nintedanib) 150 mg capsules in a quantity of 60 units, valued at $8,590.58. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and was awarded on August 22, 2025, without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for the supply of Ofev 150 mg capsules (60-count) on July 22, 2025, with completion scheduled for August 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ofev (nintedanib) 100 mg capsules in a quantity of 60 units, with a ceiling value of $8,630.28. This is a firm fixed price delivery order with an ultimate completion date of September 10, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded a delivery order valued at $17,260.58 to AmerisourceBergen Drug Corp for the supply of OFEV 100 mg capsules (60-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product being...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for 60-count bottles of Ofev 100 mg capsules, a pharmaceutical product used in the treatment of idiopathic pulmonary fibrosis. The contract, awarded on September 3, 2025, with an ultimate completion date of September 24, 2025, utilizes firm fixed pricing and represents a non-competitive set-aside delivery order. The product will be delivered to AmerisourceBergen's corporate office location in...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHMBDelivery Order
The Defense Logistics Agency awarded a $34.5K delivery order to AmerisourceBergen Drug Corp for 60-count bottles of Ofev (nintedanib) 100 mg capsules. The award was made on September 12, 2025, with an ultimate completion date of October 3, 2025, under a firm fixed-price contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.9M through December 2026, which serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company holds significant contract capacity across multiple therapeutic domains, including specialty medications, generic and brand-name drugs, and medical supplies. This competitively awarded delivery order for Ofev—a pulmonary fibrosis treatment—aligns with the company's established portfolio of specialized pharmaceutical deliveries to federal medical supply chains. AmerisourceBergen's track record of successful federal procurement performance, demonstrated through numerous competitive awards and substantial contract values, underscores its capability to meet the Defense Logistics Agency's medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.5k | 9/12/25 |